Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

The HRAS1 minisatellite locus and risk of ovarian cancer.

Weitzel JN, Ding S, Larson GP, Nelson RA, Goodman A, Grendys EC, Ball HG, Krontiris TG.

Cancer Res. 2000 Jan 15;60(2):259-61.

2.

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.

Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, Cannon-Albright L, Larsson C, Goldgar DE, Narod SA.

Nat Genet. 1996 Mar;12(3):309-11.

PMID:
8589723
3.

An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.

Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N.

N Engl J Med. 1993 Aug 19;329(8):517-23.

4.

Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.

Rosell R, Calvo R, Sánchez JJ, Maurel J, Guillot M, Monzó M, Núñez L, Barnadas A.

Clin Cancer Res. 1999 Jul;5(7):1849-54.

5.

The HRAS1 variable number of tandem repeats and risk of breast cancer.

Tamimi RM, Hankinson SE, Ding S, Gagalang V, Larson GP, Spiegelman D, Colditz GA, Krontiris TG, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1528-30.

6.

Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population.

Pierce LM, Sivaraman L, Chang W, Lum A, Donlon T, Seifried A, Wilkens LR, Lau AF, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1199-204.

7.

HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years.

Firgaira FA, Seshadri R, McEvoy CR, Dite GS, Giles GG, McCredie MR, Southey MC, Venter DJ, Hopper JL.

J Natl Cancer Inst. 1999 Dec 15;91(24):2107-11.

PMID:
10601382
8.

Rare HRAS1 alleles are a risk factor for the development of brain tumors.

Vega A, Sobrido MJ, Ruiz-Ponte C, Barros F, Carracedo A.

Cancer. 2001 Dec 1;92(11):2920-6.

PMID:
11753967
9.

Specific H-Ras minisatellite alleles in breast cancer susceptibility.

Gosse-Brun S, Sauvaigo S, Daver A, Page M, Lortholary A, Larra F, Bignon YJ, Bernard-Gallon D.

Anticancer Res. 1999 Nov-Dec;19(6B):5191-6.

PMID:
10697533
10.

Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group.

J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.

PMID:
18957670
11.

Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.

Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A.

J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23.

PMID:
11504767
12.

Hras1 VNTR alleles as susceptibility markers for lung cancer: relationship to microsatellite instability in tumors.

Lindstedt BA, Ryberg D, Zienolddiny S, Khan H, Haugen A.

Anticancer Res. 1999 Nov-Dec;19(6C):5523-7.

PMID:
10697610
13.

Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis.

Zhang C, Lv GQ, Yu XM, Gu YL, Li JP, Du LF, Zhou P.

Breast Cancer Res Treat. 2011 Jul;128(2):467-72. doi: 10.1007/s10549-011-1344-2. Epub 2011 Jan 9.

PMID:
21221763
14.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
15.

Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.

Wenham RM, Schildkraut JM, McLean K, Calingaert B, Bentley RC, Marks J, Berchuck A.

Clin Cancer Res. 2003 Oct 1;9(12):4396-403.

16.

Evolution and population genetics of the H-ras minisatellite and cancer predisposition.

Langdon JA, Armour JA.

Hum Mol Genet. 2003 Apr 15;12(8):891-900.

PMID:
12668612
17.

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.

Rutter JL, Wacholder S, Chetrit A, Lubin F, Menczer J, Ebbers S, Tucker MA, Struewing JP, Hartge P.

J Natl Cancer Inst. 2003 Jul 16;95(14):1072-8.

PMID:
12865453
18.

Ovarian cancer risk and polymorphisms involved in estrogen catabolism.

Holt SK, Rossing MA, Malone KE, Schwartz SM, Weiss NS, Chen C.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):481-9.

19.

CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.

Aktas D, Guney I, Alikasifoglu M, Yüce K, Tuncbilek E, Ayhan A.

Gynecol Oncol. 2002 Aug;86(2):124-8.

PMID:
12144816
20.

Supplemental Content

Support Center